*Acinetobacter baumannii* is an important Gram-negative pathogen frequently associated with nosocomial outbreaks worldwide and highly capable of surviving and spreading in the hospital environment. This pathogen may present high rates of multi-drug resistance including aminoglycosides and fluoroquinolones. Carbapenems usually have good potency against *A. baumannii*, but carbapenem resistance has been increasingly reported in several countries during the last decade ([@B7]). Carbapenem-hydrolysing class D β-lactamases of the oxacilinases are the most important cause of carbapenem resistance in *A. baumannii* around the world ([@B11]).

In Brazil, *A. baumannii* has become particularly problematic because of its prevalence and the carbapenems resistance, usually related to oxacilinases, mostly involving OXA-23 producers ([@B1]). Previous study reported the dissemination of two major clusters, clonal complexes (CC) 15 and 79, of multidrug-resistant *A. baumannii*in different Brazilian states harbouring *bla* ~OXA-23~ gene. The CC15 was described in nine Brazilian states \[Alagoas, Distrito Federal, Espírito Santo (ES), Goiás, Minas Gerais, Rio de Janeiro, Rio Grande do Norte, Santa Catarina and Mato Grosso do Sul\] belonging to the four different geographical regions of the country ([@B2]).

This report announces the draft genome sequence of *A. baumannii* CCBH5233 isolated in 2009 from a hospitalised patient in ES (Southeast Brazil) and deposited in the Culture Collection of Hospital-Acquired Bacteria (CCBH) located at the Hospital Infection Research Laboratory (Oswaldo Cruz Institute/Oswaldo Cruz Foundation). This strain displayed a multidrug resistance profile, which included resistance to ciprofloxacin, piperacillin/tazobactam, ampicillin/sulbactam, ceftazidime, cefepime, amikacin, sulfamethoxazole-trimethoprim, meropenem and imipenem, with the exception of polymyxin B. According to polymerase chain reaction (PCR) analysis ([@B5]), *A. baumannii* CCBH5233 has *bla* ~OXA-51-like~, originally intrinsic to *A. baumannii* and *bla* ~OXA-23-like~ genes. Previous multilocus sequence typing (MLST) analysis ([@B3]) showed that the strain belongs to sequence type (ST) 15/CC15 (according to MLST scheme developed by Pasteur Institute) ([@B2]).

Genomic DNA was extracted using QIAamp DNA Blood Mini Kit (Qiagen, Germany) and sequenced using an Illumina MiSeq sequencing platform (Illumina Inc, USA). A genomic library was constructed by transposon tagmentation with the Nextera XT DNA Sample Prep kit (Illumina Inc). The data were filtered and trimmed to a Phred score of \> 20 and were assembled *de novo* using the Velvet algorithms (Zerbino & Birney 2008). Seventy-six contigs were generated and genome annotation was performed on the Rapid Annotation using System Technology (RAST) v.2.0 (available from rast.nmpdr.org/). By RAST, 3,862 coding sequences were annotated from the genome with estimated size of 4,102,788 bp. According to tRNAScan-SE ([@B8] and RNAmmer ([@B4] analysis we identified 66 tRNAs and eight rRNAs, respectively. *A. baumannii* contigs were analysed using ResFinder 2.1 (available from cge.cbs.dtu.dk/services/ResFinder/) which identifies acquired antimicrobial resistance genes in total or partial sequenced isolates of bacteria ([@B10]. Using this approach, we observed resistance genes to betalactams \[*bla* ~OXA-51~ (LAXF01000004; 277,103-277,927 bp)~,~ *bla* ~OXA-23~(LAXF01000049; 9,858-10,679 bp) and *bla* ~TEM-1~(LAXF01000047; 5,481-6,341 bp)\], to aminoglycosides \[*aphA(6)* (LAXF01000061; 273-1,052 bp) and *aac(3)-IIa*(LAXF01000047; 4,538-5,339 bp)\] and to sulphonamide \[*sul2*(LAXF01000056; 2,580-3,395 bp)\].

In order to confirm the result obtained by traditional PCR-based MLST, *A. baumannii*contigs were analysed by MLST 1.7 server of Center for Genetic Epidemiology (available from cge.cbs.dtu.dk/services/MLST/) ([@B6]). The MLST 1.7 results showed that CCBH5233 belongs to ST15/CC15 (MLST scheme developed by Pasteur Institute) and ST236/CC104 (MLST scheme developed by University of Oxford). Additional molecular typing was performed using *Acinetobacter baumannii* Sequence Typing server (available from hpa-bioinformatics.org.uk/AB/ab_type1.php) by searching and comparing the regions of *ompA*, *csuE* and *bla* ~OXA-51~([@B9]). Using this additional typing, our strain was defined as ST502.

In summary, we reported whole-genome sequencing of the *A. baumannii* ST15 (CC15) harbouring *bla* ~OXA-23~ and a detailed genomic analysis will be provided in future studies. In the context of resistance characteristics, genes relevant to *Acinetobacter* could be identified by whole genome sequencing approaches. A detailed report of the genomic data analysis might help to understand the specific features of successful strains belonging to an important complex clonal in Brazil.

This Whole Genome Shotgun project has been deposited at DNA DataBank of Japan/European Molecular Biology Laboratory/GenBank under the accession LAXF00000000. The version described in this paper is version LAXF01000000.
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